SAC Capital Raises Stake in Amylin Pharmaceuticals, Inc. (AMLN) to 4.86%
Tweet Send to a Friend
In a 13G filing on Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN), hedge fund SAC ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
